IndieBio, established in 2014, is a San Francisco-based accelerator firm specializing in Synthetic Biology. It runs intensive four-month programs for early-stage companies and teams with innovative biological concepts. IndieBio invests in seed and early-stage startups globally, focusing on those that use biology as their core technology to solve real-world problems. The firm typically invests $250k, with an initial cash investment of $50k in exchange for an 8% equity stake. It prefers teams with at least two co-founders. IndieBio was the world's first accelerator dedicated to biology-based startups, aiming to address global challenges through innovative biotechnology.
Capra Biosciences is a biotechnology company focused on the efficient and low-carbon production of everyday chemicals through innovative bioreactor technology. The company has developed a biofilm bioreactor platform that aims to enhance the bio-manufacturing process by significantly reducing downstream processing requirements and associated costs. This technology facilitates the production of a variety of bio-based chemicals, including hydrophobic products like retinol and performance lubricants, thus advancing sustainable practices in the chemical industry.
Mothership Materials
Seed Round in 2024
Mothership Materials specializes in converting agricultural waste into valuable biomolecules. Utilizing its patented Targeted Molecular Recovery (TMR) technology, the company efficiently extracts proteins, lipids, antioxidants, sugars, and cellulose from waste streams, transforming them into feedstocks for biomanufacturing. Operating at the source of waste, Mothership Materials' modular design enables agricultural producers and waste managers to create a circular economy, maximizing the value derived from waste.
Carbonade
Seed Round in 2023
Carbonade is a chemical manufacturing company based in Ness Ziona, Israel, founded in 2022. The company specializes in innovative electro-chemical technologies for carbon capture, utilization, and storage (CCUS), focusing on the reduction of carbon dioxide emissions to address climate change. By leveraging renewable electricity, Carbonade's patented solutions offer a scalable method for converting CO2 into valuable carbon-based products such as fuels, plastics, and chemicals. This approach not only mitigates environmental impact but also provides clients with sustainable alternatives in the chemical manufacturing sector.
Capra Biosciences
Convertible Note in 2022
Capra Biosciences is a biotechnology company focused on the efficient and low-carbon production of everyday chemicals through innovative bioreactor technology. The company has developed a biofilm bioreactor platform that aims to enhance the bio-manufacturing process by significantly reducing downstream processing requirements and associated costs. This technology facilitates the production of a variety of bio-based chemicals, including hydrophobic products like retinol and performance lubricants, thus advancing sustainable practices in the chemical industry.
Capra Biosciences
Seed Round in 2020
Capra Biosciences is a biotechnology company focused on the efficient and low-carbon production of everyday chemicals through innovative bioreactor technology. The company has developed a biofilm bioreactor platform that aims to enhance the bio-manufacturing process by significantly reducing downstream processing requirements and associated costs. This technology facilitates the production of a variety of bio-based chemicals, including hydrophobic products like retinol and performance lubricants, thus advancing sustainable practices in the chemical industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.